In Brief: Pseudoephedrine, PPA reporting exemption
This article was originally published in The Tan Sheet
Executive Summary
Pseudoephedrine, PPA reporting exemption: Drug Enforcement Administration publishes interim rule Oct. 17 providing a temporary exemption from chemical registration requirements to the distributors of pseudoephedrine and phenylpropanolamine products. Registration requirements for distributors of pseudoephedrine and PPA are effective Oct. 3 under the Comprehensive Methamphetamine Control Act. Those required by the law to register with DEA in order to handle pseudoephedrine and PPA products must submit an application by Dec. 3 in order to continue distribution until final action has been taken on the application. Comments on the exemption are due Dec. 16. In a separate, same-day notice, DEA announces it is waiving a portion of the registration fee for non-retail distributors of pseudoephedrine, PPA and combination ephedrine drugs, effective immediately...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning